NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

Reminder: Submission of RiMUP for Evaluation by the Pharmacovigilance Section – Single Variation Only

Kadar pengguna: 5 / 5

bintang aktifbintang aktifbintang aktifbintang aktifbintang aktif
 

As of April 2025, all RiMUPs for evaluation by the Pharmacovigilance Section, Centre of Compliance & Quality Control (PKKK) [previously requiring manual submission] should be submitted through the QUEST 3+ system.

Important Note: RiMUP submissions for evaluation by the Pharmacovigilance Section should be submitted as a single variation only (bundling with other variation types is NOT accepted, as the evaluation will be conducted by different officers).

Please ensure all other variations are submitted and approved, BEFORE submitting the RiMUP for evaluation by the Pharmacovigilance Section (i.e., no bundling).

 

For further details, please refer to our previous announcement and the updated guidelines.

 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Jumaat 05 Disember 2025, 15:47:32.
© Copyright 2024 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA Site Map

Search